Top headlines: Tata Motors revs up EV unit; Reliance Energy signs new deal

Gennova Biopharmaceuticals is developing India's first indigenous mRNA Covid-19 vaccine, HGCO19. Read more in our top headlines of the day.

An m-RNA vaccine is in the final stages of development. Gennova Biopharmaceuticals, the biotech subsidiary of the Rs 6,056-crore Emcure Group, is developing the country’s first indigenous mRNA Covid-19 vaccine, HGCO19, that is now under advanced human trials.
 

Here are the top headlines of the day:

TPG to invest $1 billion in Tata Motors' electric vehicle subsidiary

In a boost to its electric vehicle (EV) push, Tata Motors on Tuesday closed a deal to raise Rs 7,500 crore from TPG Rise Climate and Abu Dhabi’s ADQ. This is the first major fundraising by an Indian carmaker to push clean mobility.